Table 2.
Modification | Species | Effect in Cardiac Physiology | Reference |
---|---|---|---|
GIRK1 gene ablation GIRK4 gene ablation |
Mouse | Loss of parasympathetic regulation Loss of heart rate dynamics |
[55] |
GIRK4 gene disruption | Mouse | IKACh effect in heart rate | [15] |
GIRK4 knockout mice | Mouse | Atrial fibrillation | [88] |
↑ GIRK4 mRNA in sinoatrial myocytes |
Dog | Heart failure | [89] |
GIRK blockade | Dog | Suppression of atrial arrythmias | [90] |
GIRK genetic variations | Human | Βγ-signaling pathway variations Heart-rate variations |
[94] |
GIRK4 mutation | Human | Familiar LQTS | [20] |
IKACh constitutive activation | Human | Chronic atrial fibrillation | [95,96] |
IKACh gradient current | Human | Paroxysmal atrial fibrillation | [97] |
GIRK4 overexpression | Human | Protective against adenosine-induced atrial fibrillation | [98] |
GIRK4 silencing | Human | Arrhythmia-control mechanism | [99] |
GIRK4 gain-of-function | Human | Familial SND | [101] |
GIRK overfunction | Human | Atrial fibrillation and SND | [102] |
IKACh: muscarinic receptor-activated current; SND: sinus-node dysfunction; LQTS: long QT syndrome augmented.